Shares | % | Avg Price | Total $ | |
---|---|---|---|---|
Buys | +6.36K | 100% | $44.02 | +$280K |
Sells | ||||
Net | +6.36K | 100% | +$280K |
Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
---|---|---|---|---|---|---|---|
Common Stock | 3.57M | $161M | $45.24 | May 29, 2025 | By Frazier Life Sciences IX, L.P. | ||
Common Stock | 169K | $7.63M | $45.24 | May 29, 2025 | By Frazier Life Sciences X, L.P. | ||
Common Stock | 5.7K | $258K | $45.24 | May 29, 2025 | Direct | ||
Restricted Stock Units | 0 | $146K | $25.68 | May 29, 2025 | Direct | Common Stock | |
Stock Option (right to buy) | 6.27K | May 29, 2025 | Direct | Common Stock | |||
Deferred Stock Units | 3.98K | May 29, 2025 | Direct | Common Stock |
Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|